An Analysis for Therapeutic Doses of Patients with Neuroendocrine Tumor Treated with Lutetium 177 (177Lu)-DOTATATE

Cancer Biotherapy and Radiopharmaceuticals,Volume 37, Issue 1, Page 17-22, February 2022.
Source: Cancer Biotherapy and Radiopharmaceuticals - Category: Cancer & Oncology Authors: Source Type: research